
Moving Beyond the Binary Categorization of HER2 Status: Antibody-Drug Conjugate Therapy in Metastatic Breast Cancer
Friday, September 29, 2023
6:00PM – 7:00PM ET
Please note this TeleECHO program is 6:00PM Eastern, 5:00PM Central, 4:00PM Mountain and 3:00PM Pacific.